The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
|
|---|---|
| Published in |
Frontiers in Pharmacology, October 2023
|
| DOI | 10.3389/fphar.2023.1218650 |
| Pubmed ID | |
| Authors |
José Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Jara Llenas-García, Oscar Moreno-Pérez, Inmaculada González-Cuello, Pilar Gonzalez-de-la-Aleja, Belén Martínez-López, Sergio Reus, María García-López, Juan Carlos Rodríguez, Vicente Boix, Esperanza Merino |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 6 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 1 | 17% |
| Unknown | 5 | 83% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 1 | 17% |
| Unknown | 5 | 83% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2023.
All research outputs
#19,386,653
of 24,690,130 outputs
Outputs from Frontiers in Pharmacology
#8,099
of 18,744 outputs
Outputs of similar age
#145,852
of 225,993 outputs
Outputs of similar age from Frontiers in Pharmacology
#66
of 456 outputs
Altmetric has tracked 24,690,130 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 18,744 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,993 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 456 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.